Medifast (MED) Tops Q2 EPS by 64c; Lowers Outlook
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $10.51 +3.04%
Revenue Growth %: -29.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -29.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q2 EPS of $3.87, $0.64 better than the analyst estimate of $3.23. Revenue for the quarter came in at $453.3 million versus the consensus estimate of $447.87 million.
GUIDANCE:
Medifast sees FY2022 EPS of $12.70-$14.10, versus the consensus of $15.38. Medifast sees FY2022 revenue of $1.58-1.66 billion, versus the consensus of $1.8 billion.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
